PharmTeam

Seth Robey

Seth has always had a passion for scientific discovery, particularly biology and medicine. Seth studied biochemistry at Brandeis University. Now, as a PhD student of Molecular Pharmacology at Columbia University, Seth studies the drugs that help treat cardiac arrhythmias. He's thrilled to be a Motley Fool Contributor, and uncover new and exciting scientific discoveries that could improve our approach to medicine, and provide strong long term investments. Follow @SethRobey on twitter.

PharmTeam’s Activity

Yesterday

Rule Breakers Boards Post

PharmTeam posted to the Rule Breakers boards. 11:12 AM

Thu Sep 4

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 9:06 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 8:12 PM

Tue Sep 2

Stock Advisor Boards Post

PharmTeam replied to the Stock Advisor boards. 10:27 AM

Fri Aug 29

NL

Article

PharmTeam published an article 11:36 AM

3 Reasons Eli Lilly & Co.'s Stock Could Rise

With earnings tumbling over the patent cliff, can diabetes and oncology transform Eli Lilly into a Big Pharma turnaround story?

Thu Aug 21

Stock Advisor Boards Post

PharmTeam posted to the Stock Advisor boards. 9:33 AM

Wed Aug 20

NL

Article

PharmTeam published an article 5:59 PM

5 Things Eli Lilly and Co's Management Wants You to Know

At a critical time for the company, Eli Lilly's management has laid out its plans to return to growth and gave us a good look at what the future holds.

Thu Aug 14

NL

Article

PharmTeam published an article 11:31 AM

3 Building Blocks of a Wearable Technology Revolution

The sky is the limit for wearable medical technology, but it won't be as simple as slapping a smart watch on your wrist.

Wed Aug 13

Caps Pick

PharmTeam made a pick in CAPS. 9:47 AM

Arrowhead Research Corp (ARWR) will Outperform the S&P 500

Mon Aug 4

Rule Breakers Boards Post

PharmTeam posted to the Rule Breakers boards. 12:46 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 10:19 AM

Fri Jul 25

PharmTeam recommended TMFGebinr's post on a Motley Fool Stock Advisor board. 4:29 PM

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 4:21 PM

Thu Jul 24

Stock Advisor Boards Post

PharmTeam replied to the Stock Advisor boards. 10:13 AM

Tue Jul 22

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 8:54 AM

Sat Jul 19

NL

Article

PharmTeam published an article 2:05 PM

10 Problems Electronic Health Records Can Help Solve

Electronic health records will be a central player in the future of health care and health care reform, and they may be even more useful than you might think.

Thu Jul 17

Caps Pick

PharmTeam made a pick in CAPS. 9:41 AM

Aegerion Pharmaceuticals, Inc. (AEGR) will Underperform the S&P 500

Thu Jul 10

Rule Breakers Boards Post

PharmTeam replied to the Rule Breakers boards. 11:10 PM

NL

Article

PharmTeam published an article 9:30 AM

Are Cancer Vaccines Worth an Investment?

Immuno-oncology has been the darling of biotech investors, but growth in one segment of the industry might not look as strong as you think.

Tue Jul 8

Stock Advisor Boards Post

PharmTeam posted to the Stock Advisor boards. 12:18 PM

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 82.09
Player Rank 13444 out of 75038
Score 532.51
Score Change Today +23.72
Accuracy 56.16%
Active Picks 53
Total Picks 73
Best Pick ILMN (+120.61)
Worst Pick CYTK (-76.67)
Average Score per Pick 7.29
Charms Earned 5
Highest Rated Favorite No Favorites Selected
Go to PharmTeam’s CAPS page

Boards Stats & Trivia

CAPS All Star
Board Posts 30
Recs Received 34
People who have rec'd these posts 23
Recs to Posts Ratio (last 30 days) N/A
Threads Started 11
Threads Started Percentage 36.67 %
Most Frequent Board Motley Fool Rule Breakers
Very First Post A SAS: Amazon.com post. (12/1/2013)
Percentage of Posts Rec'd 53.33 %
Show PharmTeam’s 10 Latest Posts